Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1993; 69(05): 448-453
DOI: 10.1055/s-0038-1651631

Original Article

Coagulation

Schattauer GmbH Stuttgart

Activation of Protein C and Its Distribution between Its Inhibitors, Protein C Inhibitor, α₁-Antitrypsin and α₂-Macroglobulin, in Patients with Disseminated intravascular Coagulation

M F Scully

¹The Department of Haematology, Royal Victoria Hospital Montreal, Quebec

,

C H Toh

The Departments of Pathology, Biochemistry and Medicine Queen’s University, Kingston, Ontario, Canada

,

H Hoogendoorn

The Departments of Pathology, Biochemistry and Medicine Queen’s University, Kingston, Ontario, Canada

,

R P Manuel

The Departments of Pathology, Biochemistry and Medicine Queen’s University, Kingston, Ontario, Canada

,

M E Nesheim

The Departments of Pathology, Biochemistry and Medicine Queen’s University, Kingston, Ontario, Canada

,

S Solymoss

¹The Department of Haematology, Royal Victoria Hospital Montreal, Quebec

,

A R Giles

The Departments of Pathology, Biochemistry and Medicine Queen’s University, Kingston, Ontario, Canada

› Author Affiliations

Summary

Activation and inactivation of protein C during the clinical course of disseminated intravascular coagulation (DIC) was studied in three patients by qualitative (Western blotting) and quantitative (ELISA) analysis and the intensity of procoagulant activity monitored by the measurement of thrombin and factor Xa antithrombin III complexes. In one patient, inhibitor complexes of APC with protein C inhibitor (PCI) and α₁-antitrypsin (α₁-AT) were observed and the latter predominated at presentation. Both disappeared during the development of remission but the loss of α₁-AT complexes preceded PCI complexes which on Western blotting appeared to increase in intensity prior to disappearance. The two other patients bled to death from uncontrollable haemorrhage. In both cases, APC/inhibitor complexes with α₂-macroglobulin (α₂-M) in addition to PCI and α_r-AT were detected and persisted until death. Although PCI appeared to be the primary inhibitor in all three cases, α₁-antitrypsin and particularly α₂-macroglobulin appeared to assume greater roles in the two fatal cases. These data are similar to previous findings in an experimental animal model of DIC that suggested that α₂-macroglobulin and α₁-antitrypsin become more important inhibitors of APC as the primary inhibitor PCI is consumed in the face of a sustained procoagulant challenge.

References
1 McKay DG. Disseminated Intravascular Coagulation. New York: Harper-Hoeber; 1965: 493
2 Deykin D. The clinical challenge of disseminated intravascular coagulation. N Engl J Med 1970; 283: 636-644
3 Giles AR, Nesheim ME, Mann KG. Studies of factors V and VIII: C in an animal model of disseminated intravascular coagulation. J Clin Invest 1984; 74: 2219-2225
4 Giles AR, Mann KG, Nesheim ME. A Combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo. Br J Haematol 1988; 69: 491-497
5 Hoogendoorn H, Nesheim ME, Giles AR. A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model. Blood 1990; 75: 2164-2171
6 Hoogendoorn H, Toh CH, Nesheim ME. et al. Alpha-2-Macroglobulin binds and inhibits activated protein C. Blood 1991; 78: 2283-2290
7 Heeb MJ, Mosher DF, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood 1989; 73: 455-461
8 Tracy PB, Giles AR, Mann KG. et al. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984; 74: 1221-1228
9 Clauss VA. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
10 Koide T. Isolation and characterization of antithrombin III from human, porcine and rabbit plasma, and rat serum. J Biochem 1979; 86: 1841-1850
11 Hall PK, Roberts RC. Physical and chemical properties of human plasma alpha(2)-macroglobulin. Biochem J 1978; 171: 27-38
12 Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709
13 Suzuki K, Nishioka J, Kusumoto H. et al. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-195
14 Butkowski RJ, Elion J, Downing MR. et al. Primary structure of human prethrombin 2 and alpha thrombin. J Biol Chem 1977; 252: 4942-4957
15 Kisiel WK. Human plasma protein C. Isolation, characterization, and mechanism of activation by (alpha)-thrombin. J Clin Invest 1979; 64: 761-769
16 DiScipio RG, Hermodson MA, Yates SG. et al. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977; 16: 698-705
17 Heeb MJ, Gruber A, Griffin JH. Identification of divalent metal iondependent inhibition of activated protein C by alpha(2)-Macroglobulin and alpha(2)-Antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. J Biol Chem 1991; 266: 17606-17612
18 Espana F, Vicente V, Tabernero D. et al. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res 1990; 59: 593-608
19 Griffin JH, Mosher DF, Zimmerman TS. et al. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261-264
20 Mimuro J, Sakata Y, Wakabayashi K. et al. Level of protein C determined by combined assays during disseminated intravascular coagulation and oral anticoagulation. Blood 1987; 69: 1704-1711
21 Laurell M, Stenflo J, Carlson TH. Turnover of I-protein C inhibitor and I-alpha(1)-Antitrypsin and their complexes with activated protein C. Blood 1990; 76: 2290-2295
22 Espana F, Gruber A, Heeb MJ. et al. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons. Blood 1991; 77: 1754-1760
23 Taylor Jr FB, Hoogendoorn H, Chang ACK. et al. Anticoagulant and fibrinolytic activities are promoted not retarded in vivo following thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 1992; 79: 1720-1728
24 Giles AR, Nesheim ME, Herring SW. et al. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemostas 1990; 63: 476-481
25 Clouse LH, Comp PC. The regulation of hemostasis: The protein C system. N Engl J Med 1986; 314: 1298-1304
26 Marder VJ, Martin SE, Francis CW. et al. Consumptive throm-bohemorrhagic disorders. In: Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ. et al. (eds). Philadelphia: Lippincott; 1987: 975-1015
27 Taylor Jr FB, Chang A, Esmon CT. et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-925
28 Okajima K, Imamura H, Koga S. et al. Treatment of patients with disseminated intravascular coagulation by protein C. Am J Hematol 1990; 33: 277-278